Contact
searchSearch
HMP Global

Psoriatic Arthritis News

News
Deucravacitinib Improves Fatigue and Quality of Life in Psoriatic Arthritis, Phase 3 Pooled Analysis Shows
04/01/2026
Riya Gandhi, MA
Significant gains in physical, mental, and social functioning highlight the drug’s impact beyond joint symptoms.
Significant gains in physical, mental, and social functioning highlight the drug’s impact beyond joint symptoms.
Significant gains in physical,...
04/01/2026
The Dermatologist
News
Bimekizumab Demonstrates Sustained 3-Year Efficacy Across Joint, Skin, and Nail Domains in Psoriatic Arthritis
03/31/2026
Riya Gandhi, MA
Phase 3 data show durable responses and consistent safety in both biologic-naïve and TNFi-experienced patients with PsA and psoriasis.
Phase 3 data show durable responses and consistent safety in both biologic-naïve and TNFi-experienced patients with PsA and psoriasis.
Phase 3 data show durable...
03/31/2026
The Dermatologist
psoriatic arthritis
News
Risankizumab Maintains Radiographic Nonprogression Through 5 Years in Psoriatic Arthritis
03/30/2026
Riya Gandhi, MA
Five-year data from the phase 3 KEEPsAKE 1 trial show that risankizumab maintains low rates of radiographic progression in patients with active psoriatic arthritis.
Five-year data from the phase 3 KEEPsAKE 1 trial show that risankizumab maintains low rates of radiographic progression in patients with active psoriatic arthritis.
Five-year data from the phase 3...
03/30/2026
The Dermatologist
psoriatic arthritis
News
Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap
09/02/2025
Jessica Garlewicz
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Real-World Data Support ITABIO Guidelines for Second-Line Biologic Use in Inflammatory Arthritis
09/02/2025
Jessica Garlewicz
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Integrated PsA Screening Framework Improves Outcomes in Dermatology Clinics
08/14/2025
Jessica Garlewicz
The study highlights a scalable clinical model that integrates validated screening tools into routine dermatologic care.
The study highlights a scalable clinical model that integrates validated screening tools into routine dermatologic care.
The study highlights a scalable...
08/14/2025
The Dermatologist
psoriatic arthritis
News
Study Finds Higher Fertility Rates Among Men With Inflammatory Joint Disease
08/14/2025
Jessica Garlewicz
A nationwide cohort study from Norway challenges assumptions about reproductive health in men with inflammatory joint diseases.
A nationwide cohort study from Norway challenges assumptions about reproductive health in men with inflammatory joint diseases.
A nationwide cohort study from...
08/14/2025
The Dermatologist
psoriatic arthritis
News
TNF Inhibitors Improve Clinical Outcomes in csDMARD-Inadequate Psoriatic Arthritis, Review Finds
07/22/2025
Jessica Garlewicz
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists,...
07/22/2025
The Dermatologist
psoriatic arthritis
News
IL-23/IL-17 Axis Central to Psoriatic Arthritis Pathogenesis, Study Finds
07/10/2025
Jessica Garlewicz
Targeted intervention at the level of the IL-23/IL-17 axis may not only control clinical symptoms but also interrupt disease progression and systemic inflammation.
Targeted intervention at the level of the IL-23/IL-17 axis may not only control clinical symptoms but also interrupt disease progression and systemic inflammation.
Targeted intervention at the...
07/10/2025
The Dermatologist
psoriatic arthritis
News
IL-23 and IL-17 Inhibitors Linked to Lower Risk of Psoriatic Arthritis in Patients with Plaque Psoriasis
06/17/2025
Jessica Garlewicz
In patients at increased risk for PsA, IL-23 or IL-17 inhibitors may offer added benefit in mitigating progression to joint involvement.
In patients at increased risk for PsA, IL-23 or IL-17 inhibitors may offer added benefit in mitigating progression to joint involvement.
In patients at increased risk...
06/17/2025
The Dermatologist

Popular Articles

Nodular, Ulcerated Lesion on the Lower Mucosal Lip
Case Report
What Caused This Nodular, Ulcerated Lesion on the Lower Mucosal Lip?
04/30/2024
Amor Khachemoune, MD, FAAD, FACMS
A 69-year-old man with a history notable for nonmelanoma skin cancer and being a nonsmoker sought dermatologic evaluation for a persistent, nonhealing lesion on his right lower lip.
A 69-year-old man with a history notable for nonmelanoma skin cancer and being a nonsmoker sought dermatologic evaluation for a persistent, nonhealing lesion on his right lower lip.
A 69-year-old man with a history...
04/30/2024
The Dermatologist
skin cancer
News
Establishing a Novel Model for Studying Neural Invasion in Non-Melanoma Skin Cancer
05/15/2024
Jessica Garlewicz
Researchers aimed to develop a 3-dimensional model of neural invasion in squamous cell carcinoma to better understand its underlying biologic mechanisms, which are still poorly understood.
Researchers aimed to develop a 3-dimensional model of neural invasion in squamous cell carcinoma to better understand its underlying biologic mechanisms, which are still poorly understood.
Researchers aimed to develop a...
05/15/2024
The Dermatologist
Atopic dermatitis
News
Improving Biomarkers in Atopic Dermatitis: Insights from Lebrikizumab Studies
06/21/2024
Riya Gandhi, MA
In recent findings from the ADvocate1 and ADvocate2 studies, lebrikizumab has shown promising results in treating moderate-to-severe atopic dermatitis.
In recent findings from the ADvocate1 and ADvocate2 studies, lebrikizumab has shown promising results in treating moderate-to-severe atopic dermatitis.
In recent findings from the...
06/21/2024
The Dermatologist
skin cancer
News
Esophageal Squamous Cell Carcinoma Under Iodine Staining
08/09/2024
Jessica Garlewicz
Researchers aimed to evaluate the effects of texture and color enhancement imaging on improving the endoscopic visibility of esophageal squamous cell carcinoma under iodine staining.
Researchers aimed to evaluate the effects of texture and color enhancement imaging on improving the endoscopic visibility of esophageal squamous cell carcinoma under iodine staining.
Researchers aimed to evaluate...
08/09/2024
The Dermatologist
Spotlight
A Conversation With Matilde Iorizzo, MD, PhD
10/07/2024
Benjamin Barankin, MD, FRCPC
Dr Matilde Iorizzo is a dermato-venereologist with specific areas of interest in hair and nail disorders.
Dr Matilde Iorizzo is a dermato-venereologist with specific areas of interest in hair and nail disorders.
Dr Matilde Iorizzo is a...
10/07/2024
The Dermatologist
cover March 2026

Current Issue

March 2026
Volume 34
Issue 2
Current Issue
Issue Archive

Latest Quizzes and Trivia

Quiz
Type 2 Inflammation and Early Systemic Therapy in Pediatric Atopic Dermatitis
04/05/2026
Riya Gandhi, MA
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical...
04/05/2026
The Dermatologist
Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist
psoriasis
Quiz
Quiz: Misdiagnosis of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized...
03/02/2026
The Dermatologist
Quiz
Allergic Disease Progression: Genetics and Environment
02/26/2026
Riya Gandhi, MA
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between...
02/26/2026
The Dermatologist
Quiz
Early Intervention Strategies in Pediatric Atopic Dermatitis
02/26/2026
Riya Gandhi, MA
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of...
02/26/2026
The Dermatologist
Quiz
Air Pollution and Atopic Disease: Evaluating Epidemiologic Evidence
02/26/2026
Riya Gandhi, MA
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the...
02/26/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use